MEREU , Carlo

Last name: MEREU

First name: Carlo

1986 (v1)

Publication

Metadata-only

Regional lung function following sleeve lobectomy.

Ratto GB Sacco A Villa G

No description

Uploaded on: April 14, 2023
1986 (v1)

Publication

Metadata-only

Nasal and bronchial IgE in allergic and intrinsic patients.

CRIMI, EMANUELE MEREU, CARLO Crimi P

No description

Uploaded on: April 14, 2023
1986 (v1)

Publication

Metadata-only

The effect of bromhexine on phospholipid concentration in bronchial and bronchoalveolar lavage.

Crimi P Zupo S Mantellini E

No description

Uploaded on: March 31, 2023
2001 (v1)

Publication

Metadata-only

Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis

CRIMI, EMANUELE MEREU, CARLO RICCIO, ANNA MARIA

No description

Uploaded on: April 14, 2023
1996 (v1)

Publication

Metadata-only

Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony stimulating factor with or without antimicrobial prophylaxis in patients with small cell lung cancer

ARDIZZONI A PENNUCCI MC DANOVA M

No description

Uploaded on: April 14, 2023
2011 (v1)

Publication

Metadata-only

Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD

BRUSASCO, VITO CANONICA, GIORGIO Dal Negro R

No description

Uploaded on: April 14, 2023
2015 (v1)

Publication

Metadata-only

Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study

BRAIDO, FULVIO Baiardini, Ilaria Scichilone, Nicola

Background: The role of disability and its association with patient-reported outcomes in the nonsevere forms of chronic obstructive pulmonary disease (COPD) has never been explored. Objectives: The aim of this study was to assess, in a cross-sectional real-life study, the prevalence and degree of disability in moderate COPD patients and to...

Uploaded on: October 11, 2023
2014 (v1)

Publication

Metadata-only

The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial

BRAIDO, FULVIO Melioli, Giovanni Candoli, Piero

Studies in the 1970s and 1980s reported that bacterial lysates (BL) had a prophylactic effect on recurrent respiratory tract infections (RRTI). However, controlled clinical study procedures have evolved substantially since then. We performed a trial using updated methods to evaluate the efficacy of Lantigen B®, a chemical BL. This double blind,...

Uploaded on: April 14, 2023

MEREU , Carlo

Recent uploads